Copyright © 2010 Mineki Saito. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. Y. Hinuma, Nagata, M. Hanaoka, et al., “Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 10, pp. 6476–6480, 1981. View at Scopus
2. M. Yoshida, M. Seiki, K. Yamaguchi, and K. Takatsuki, “Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 8, pp. 2534–2537, 1984. View at Scopus
3. M. Osame, K. Usuku, S. Izumo, et al., “HTLV-I associated myelopathy, a new clinical entity,” The Lancet, vol. 1, no. 8488, pp. 1031–1032, 1986. View at Scopus
4. A. Gessain, F. Barin, J. C. Vernant, et al., “Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis,” The Lancet, vol. 2, no. 8452, pp. 407–410, 1985. View at Scopus
5. K. Verdonck, E. González, S. Van Dooren, A.-M. Vandamme, G. Vanham, and E. Gotuzzo, “Human T-lymphotropic virus 1: recent knowledge about an ancient infection,” The Lancet Infectious Diseases, vol. 7, no. 4, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
6. G. de The and R. Bomford, “An HTLV-I vaccine: why, how, for whom?” AIDS Research and Human Retroviruses, vol. 9, no. 5, pp. 381–386, 1993. View at Scopus
7. T. Uchiyama, “Human T cell leukemia virus type I (HTLV-I) and human diseases,” Annual Review of Immunology, vol. 15, pp. 15–37, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
8. F. A. Proietti, A. B. F. Carneiro-Proietti, B. C. Catalan-Soares, and E. L. Murphy, “Global epidemiology of HTLV-I infection and associated diseases,” Oncogene, vol. 24, no. 39, pp. 6058–6068, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
9. D. F. Roucoux, B. Wang, D. Smith, et al., “A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II,” Journal of Infectious Diseases, vol. 191, no. 9, pp. 1490–1497, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
10. S. Hino, K. Yamaguchi, S. Katamine, et al., “Mother-to-child transmission of human T-cell leukemia virus type-I,” Japanese Journal of Cancer Research, vol. 76, no. 6, pp. 474–480, 1985. View at Scopus
11. K. Kinoshita, T. Amagasaki, S. Hino, et al., “Milk-borne transmission of HTLV-I from carrier mothers to their children,” Japanese Journal of Cancer Research, vol. 78, no. 7, pp. 674–680, 1987.
12. M. Nakagawa, K. Nakahara, Y. Maruyama, et al., “Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis,” Journal of NeuroVirology, vol. 2, no. 5, pp. 345–355, 1996. View at Scopus
13. M. Osame, R. Janssen, H. Kubota, et al., “Nationwide survey of HTLV-I-asscociated myelopathy in Japan: association with blood transfusion,” Annals of Neurology, vol. 28, no. 1, pp. 50–56, 1990. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. M. Hisada, S. O. Stuver, A. Okayama, et al., “Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers,” Journal of Infectious Diseases, vol. 190, no. 9, pp. 1605–1609, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
15. M. Nakagawa, S. Izumo, S. Ijichi, et al., “HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings,” Journal of Neurovirology, vol. 1, no. 1, pp. 50–61, 1995. View at Scopus
16. A. Kramer, E. M. Maloney, O. S. C. Morgan, et al., “Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica,” American Journal of Epidemiology, vol. 142, no. 11, pp. 1212–1220, 1995.
17. Y. Iwasaki, “Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP),” Journal of the Neurological Sciences, vol. 96, no. 1, pp. 103–123, 1990. View at Publisher · View at Google Scholar · View at Scopus
18. A. Yoshioka, G. Hirose, Y. Ueda, Y. Nishimura, and K. Sakai, “Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM),” Journal of Neurology Neurosurgery and Psychiatry, vol. 56, no. 9, pp. 1004–1007, 1993. View at Scopus
19. S. Izumo, F. Umehara, and M. Osame, “HTLV-I-associated myelopathy,” Neuropathology, vol. 20, supplement, pp. S65–S68, 2000. View at Scopus
20. S. Jacobson, “Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease,” Journal of Infectious Diseases, vol. 186, supplement 2, pp. S187–S192, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
21. N. Takenouchi, Y. Yamano, K. Usuku, M. Osame, and S. Izumo, “Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis,” Journal of NeuroVirology, vol. 9, no. 1, pp. 29–35, 2003. View at Scopus
22. M. Nagai, Y. Yamano, M. B. Brennan, C. A. Mora, and S. Jacobson, “Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific $\text{CD}{8}^{+}$ T cells in cerebrospinal fluid from patients with HAM/TSP,” Annals of Neurology, vol. 50, no. 6, pp. 807–812, 2001. View at Publisher · View at Google Scholar · View at Scopus
23. D. Hayashi, R. Kubota, N. Takenouchi, et al., “Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy,” Journal of NeuroVirology, vol. 14, no. 5, pp. 459–463, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. M. Nagai, K. Usuku, W. Matsumoto, et al., “Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP,” Journal of NeuroVirology, vol. 4, no. 6, pp. 586–593, 1998. View at Scopus
25. A. Manns, W. J. Miley, R. J. Wilks, et al., “Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection,” Journal of Infectious Diseases, vol. 180, no. 5, pp. 1487–1493, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. V. Adaui, K. Verdonck, I. Best, et al., “SYBR green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness,” Journal of NeuroVirology, vol. 12, no. 6, pp. 456–465, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. A. H. Sabouri, M. Saito, K. Usuku, et al., “Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals,” Journal of General Virology, vol. 86, no. 3, pp. 773–781, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
28. K. J. M. Jeffery, A. A. Siddiqui, M. Bunce, et al., “The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection,” Journal of Immunology, vol. 165, no. 12, pp. 7278–7284, 2000. View at Scopus
29. K. J. M. Jeffery, K. Usuku, S. E. Hall, et al., “HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 7, pp. 3848–3853, 1999. View at Publisher · View at Google Scholar · View at Scopus
30. A. M. Vine, A. D. Witkover, A. L. Lloyd, et al., “Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis,” Journal of Infectious Diseases, vol. 186, no. 7, pp. 932–939, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. D. Kodama, M. Saito, W. Matsumoto, et al., “Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP),” Journal of Neuroimmunology, vol. 156, no. 1-2, pp. 188–194, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
32. A. H. Sabouri, M. Saito, A. L. Lloyd, et al., “Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis,” Journal of Infectious Diseases, vol. 190, no. 7, pp. 1279–1285, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
33. Y. Furukawa, M. Yamashita, K. Usuku, S. Izumo, M. Nakagawa, and M. Osame, “Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis,” Journal of Infectious Diseases, vol. 182, no. 5, pp. 1343–1349, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
34. J. Kira, M. Nakamura, T. Sawada, et al., “Antibody titers to HTLV-I-$\text{p}{40}^{\text{tax}}$ protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load,” Journal of the Neurological Sciences, vol. 107, no. 1, pp. 98–104, 1992. View at Publisher · View at Google Scholar · View at Scopus
35. S. Ishihara, A. Okayama, S. Stuver, et al., “Association of HTLV-I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells,” Journal of Acquired Immune Deficiency Syndromes, vol. 7, no. 2, pp. 199–203, 1994.
36. K. Nagasato, T. Nakamura, S. Shirabe, et al., “Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy,” Journal of the Neurological Sciences, vol. 103, no. 2, pp. 203–208, 1991. View at Publisher · View at Google Scholar · View at Scopus
37. R. B. Lal, C.-Z. Giam, J. E. Coligan, and D. L. Rudolph, “Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy,” Journal of Infectious Diseases, vol. 169, no. 3, pp. 496–503, 1994. View at Scopus
38. M. C. Levin, S. M. Lee, F. Kalume, et al., “Autoimmunity due to molecular mimicry as a cause of neurological disease,” Nature Medicine, vol. 8, no. 5, pp. 509–513, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
39. G. Dreyfuss, M. J. Matunis, S. Pinol-Roma, and C. G. Burd, “hnRNP proteins and the biogenesis of mRNA,” Annual Review of Biochemistry, vol. 62, pp. 289–321, 1993. View at Scopus
40. F. Yu, Y. Itoyama, K. Fujihara, and I. Goto, “Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals,” Journal of Neuroimmunology, vol. 33, pp. 121–128, 1991.
41. M. Saito, V. M. Braud, P. Goon, et al., “Low frequency of CD94/NKG2A⁺ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers,” Blood, vol. 102, no. 2, pp. 577–584, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
42. K. Azakami, T. Sato, N. Araya, et al., “Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders,” Blood, vol. 114, no. 15, pp. 3208–3215, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
43. L. C. Ndhlovu, J. E. Snyder-Cappione, K. I. Carvalho, et al., “Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease,” Clinical and Experimental Immunology, vol. 158, no. 3, pp. 294–299, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
44. T. Matsuzaki, M. Saito, K. Usuku, et al., “A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis,” Journal of the Neurological Sciences, vol. 237, no. 1-2, pp. 75–81, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
45. Y. Yamano, N. Takenouchi, H.-C. Li, et al., “Virus-induced dysfunction of CD4⁺CD25⁺ T cells in patients with HTLV-I-associated neuroimmunological disease,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1361–1368, 2005. View at Publisher · View at Google Scholar · View at Scopus
46. S. Sakaguchi, M. Ono, R. Setoguchi, et al., “Foxp3⁺CD25⁺CD4⁺ natural regulatory T cells in dominant self-tolerance and autoimmune disease,” Immunological Reviews, vol. 212, pp. 8–27, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
47. U. Oh, C. Grant, C. Griffith, K. Fugo, N. Takenouchi, and S. Jacobson, “Reduced Foxp3 protein expression is associated with inflammatory disease during human T lymphotropic virus type 1 infection,” Journal of Infectious Diseases, vol. 193, no. 11, pp. 1557–1566, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
48. D. Hayashi, R. Kubota, N. Takenouchi, et al., “Reduced Foxp3 expression with increased cytomegalovirus-specific CTL in HTLV-I-associated myelopathy,” Journal of Neuroimmunology, vol. 200, no. 1-2, pp. 115–124, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. F. Toulza, A. Heaps, Y. Tanaka, G. P. Taylor, and C. R. M. Bangham, “High frequency of CD4⁺FoxP3⁺ cells in HTLV-1 infection: inverse correlation with HTLV-l-specific CTL response,” Blood, vol. 111, no. 10, pp. 5047–5053, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
50. I. Best, G. López, K. Verdonck, et al., “IFN-$\gamma$ production in response to Tax 161-233, and frequency of CD4⁺ Foxp3⁺ and Lin-HLA-DRhigh CD123⁺ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population,” Immunology, vol. 128, no. 1, part 2, pp. e777–e786, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
51. J. Inoue, M. Seiki, T. Taniguchi, S. Tsuru, and M. Yoshida, “Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1,” EMBO Journal, vol. 5, no. 11, pp. 2883–2888, 1986. View at Scopus
52. B. Kitze, K. Usuku, Y. Yamano, et al., “Human CD4⁺ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1^∗0101,” Clinical and Experimental Immunology, vol. 111, no. 2, pp. 278–285, 1998. View at Publisher · View at Google Scholar · View at Scopus
53. P. K. C. Goon, T. Igakura, E. Hanon, et al., “Human T cell lymphotropic virus type I (HTLV-I)-specific CD4⁺ T cells: immunodominance hierarchy and preferential infection with HTLV-I,” Journal of Immunology, vol. 172, no. 3, pp. 1735–1743, 2004. View at Scopus
54. M. Kannagi, S. Harada, I. Maruyama, et al., “Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8⁺ cytotoxic T cells directed against HTLV-I-infected cells,” International Immunology, vol. 3, no. 8, pp. 761–767, 1991.
55. S. Jacobson, H. Shida, D. E. McFarlin, A. S. Fauci, and S. Koenig, “Circulating CD8⁺ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease,” Nature, vol. 348, no. 6298, pp. 245–248, 1990. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
56. P. K. C. Goon, A. Biancardi, N. Fast, et al., “Human T cell lymphotropic virus (HTLV) type-1-specific CD8⁺ T cells: frequency and immunodominance hierarchy,” Journal of Infectious Diseases, vol. 189, no. 12, pp. 2294–2298, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
57. H. Nose, R. Kubota, N. P. Seth, et al., “Ex vivo analysis of human T lymphotropic virus type 1-specific CD4⁺ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide,” Journal of Infectious Diseases, vol. 196, no. 12, pp. 1761–1772, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
58. P. K. C. Goon, E. Hanon, T. Igakura, et al., “High frequencies of Th1-type CD4⁺ T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis,” Blood, vol. 99, no. 9, pp. 3335–3341, 2002. View at Publisher · View at Google Scholar · View at Scopus
59. P. K. C. Goon, T. Igakura, E. Hanon, et al., “High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4⁺ T cells in patients with HTLV-1-associated neurological disease,” Journal of Virology, vol. 77, no. 17, pp. 9716–9722, 2003. View at Publisher · View at Google Scholar · View at Scopus
60. M. Saito, G. P. Taylor, A. Saito, et al., “In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes,” Journal of Virology, vol. 75, no. 2, pp. 1065–1071, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
61. M. Saito, I. Higuchi, A. Saito, et al., “Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis,” Journal of Infectious Diseases, vol. 186, no. 9, pp. 1231–1241, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
62. C. R. M. Bangham, “The immune response to HTLV-I,” Current Opinion in Immunology, vol. 12, no. 4, pp. 397–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
63. E. Hanon, S. Hall, G. P. Taylor, et al., “Abundant Tax protein expression in CD4⁺ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes,” Blood, vol. 95, no. 4, pp. 1386–1392, 2000. View at Scopus
64. T. F. Greten, J. E. Slansky, R. Kubota, et al., “Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8⁺ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7568–7573, 1998. View at Scopus
65. M. Nagai, R. Kubota, T. F. Greten, J. P. Schneck, T. P. Leist, and S. Jacobson, “Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8⁺ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load,” Journal of Infectious Diseases, vol. 183, no. 2, pp. 197–205, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. R. Kubota, T. Kawanishi, H. Matsubara, A. Manns, and S. Jacobson, “Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8⁺ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection,” Journal of Immunology, vol. 161, no. 1, pp. 482–488, 1998. View at Scopus
67. A. H. Sabouri, K. Usuku, D. Hayashi, et al., “Impaired function of human T-lymphotropic virus type 1 (HTLV-1) specific CD8⁺ T cells in HTLV-1 associated neurologic disease,” Blood, vol. 112, no. 6, pp. 2411–2420, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
68. S. E. Macatonia, J. K. Cruickshank, P. Rudge, and S. C. Knight, “Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation,” AIDS Research and Human Retroviruses, vol. 8, no. 9, pp. 1699–1706, 1992. View at Scopus
69. A. Ali, S. Patterson, K. Cruickshank, P. Rudge, A. G. Dalgleish, and S. C. Knight, “Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis,” Clinical and Experimental Immunology, vol. 94, no. 1, pp. 32–37, 1993. View at Scopus
70. Y. Itoyama, S. Minato, J. Kira, et al., “Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy,” Neurology, vol. 38, no. 8, pp. 1302–1307, 1988. View at Scopus
71. S. Ijichi, N. Eiraku, M. Osame, et al., “In vitro modulation of lymphocyte proliferation by prednisolone and interferon-$\alpha$ in patients with HTLV-I-associated myelopathy (HAM),” Journal of Neuroimmunology, vol. 23, no. 2, pp. 175–178, 1989. View at Scopus
72. M. Makino, M. Azuma, S.-I. Wakamatsu, et al., “Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type iassociated myelopathy/tropical spastic paraparesis,” Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 3, pp. 316–322, 1999. View at Scopus
73. K. S. Jones, C. Petrow-Sadowski, Y. K. Huang, D. C. Bertolette, and F. W. Ruscetti, “Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4⁺ T cells,” Nature Medicine, vol. 14, no. 4, pp. 429–436, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
74. Y. Yamano, C. J. Cohen, N. Takenouchi, et al., “Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A^∗201 complexes on CD4⁺ CD25⁺ T cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease,” Journal of Experimental Medicine, vol. 199, no. 10, pp. 1367–1377, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
75. S. L. Manuel, T. D. Schell, E. Acheampong, S. Rahman, Z. K. Khan, and P. Jain, “Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease,” Journal of Leukocyte Biology, vol. 86, no. 5, pp. 1205–1216, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
76. Y. Koyanagi, Y. Itoyama, N. Nakamura, et al., “In vivo infection of human T-cell leukemia virus type 1 in non-T cells,” Virology, vol. 196, no. 1, pp. 25–33, 1993. View at Publisher · View at Google Scholar · View at Scopus
77. C. Grant, K. Barmak, T. Alefantis, J. Yao, S. Jacobson, and B. Wigdahl, “Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation,” Journal of Cellular Physiology, vol. 190, no. 2, pp. 133–159, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
78. M. Abe, F. Umehara, R. Kubota, T. Moritoyo, S. Izumo, and M. Osame, “Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy,” Journal of Neurology, vol. 246, no. 5, pp. 358–364, 1999. View at Publisher · View at Google Scholar · View at Scopus
79. M. C. Levin, M. Krichavsky, R. J. Fox, et al., “Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease,” Blood, vol. 89, no. 1, pp. 346–348, 1997. View at Scopus
80. K. Nagafuji, M. Harada, T. Teshima, et al., “Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type 1,” Blood, vol. 82, no. 9, pp. 2823–2828, 1993. View at Scopus